Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/Sinovac Biotech, Ltd./ 6-K

SEC Filing · 6-K

Sinovac Biotech, Ltd.

SVANASDAQEQUITYCurrent

SEC Filing

Filed Jul 15, 2026Accepted Jul 15, 2026, 2:09 AM EDTCIK 1084201Accession 0001213900-26-078116
View company →Permanent SEC source ↗
Share

Company context

Current securities

SVANASDAQ · EQUITY · Current

Recent company filings

  1. 6-K filingAug 17, 2026
  2. 6-K filingJun 15, 2026
  3. 6-K filingJun 5, 2026
  4. 20-F filingJun 5, 2026
  5. 6-K filingMay 29, 2026

As-filed source

Primary evidence
As filedOpen full document ↗